Louisiana 2023 Regular Session

Louisiana House Bill HB122

Introduced

3/16/23

Introduced

3/16/23

Refer

3/16/23

Refer

4/10/23

Refer

4/10/23

Report Pass

4/20/23

Report Pass

4/20/23

Provides relative to the mandatory screening of all newborns for early detection of the cytomegalovirus (CMV) (OR NO IMPACT See Note)

No companion bills found.

Requires screening of newborns for Krabbe disease (EN +$798,907 GF EX See Note)

Provides relative to newborn screening for certain genetic conditions (EN SEE FISC NOTE GF EX See Note)

Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel (EN +$187,717 GF EX See Note)

Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel

AN ACT relating to newborn and infant screenings.

AN ACT relating to newborn and infant screenings.

Requires all newborns to be screened for adrenoleukodystrophy

Provides relative to cytomegalovirus (CMV) testing for newborns (EN GF EX See Note)

Relating to requiring the Health Department to mandate mucopolysaccharidosis type 1 (MPS1) test for newborn babies, to be known as Embie’s Law

An Act Concerning Newborn Screening For Cytomegalovirus And Establishing A Public Education Program For Cytomegalovirus.

No similar bills found.